HF Readmission | |||
---|---|---|---|
Variable | Hazard ratio | 95% CI | p-value |
LV GLS –14.15 to –10.55 | 3.144 | 1.46–6.74 | 0.003 |
LV GLS –10.54 to 6.41 | 7.40 | 3.55–15.39 | <0.001 |
LV GLS > −6.41 | 7.87 | 3.79–16.34 | <0.001 |
LV GLS as a continuous variable a | 1.17 | 1.12–1.23 | <0.001 |
LVEF | 0.97 | 0.96–0.98 | <0.001 |
Age | 1.01 | 0.99–1.02 | 0.099 |
Male | 1.11 | 0.77–1.61 | 0.566 |
NYHA functional class II | 1.3 | 0.77–2.19 | 0.314 |
NYHA functional class III | 2.01 | 1.18–3.41 | 0.01 |
NYHA functional class IV | 0.92 | 0.12–6.87 | 0.937 |
Systolic blood pressure | 0.98 | 0.98–0.99 | <0.001 |
Diastolic blood pressure | 0.99 | 0.98–0.99 | 0.025 |
Heart rate | 1 | 0.99–1.01 | 0.137 |
Creatinine | 0.9 | 0.82–1 | 0.052 |
Sodium level | 0.93 | 0.88–0.98 | 0.018 |
History of ischemic heart disease | 1.55 | 1.07–2.24 | 0.021 |
Diabetes | 1 | 0.68–1.46 | 0.983 |
Hypertension | 1.45 | 0.59–3.55 | 0.418 |
Dementia | 12.18 | 1.54–95.95 | 0.018 |
Chronic obstructive pulmonary disease | 1.24 | 0.76–2.01 | 0.382 |
ACEI-ARBs | 1.83 | 1.17–2.86 | 0.008 |